Bethlem myopathy: long-term follow-up identifies COL6 mutations predicting severe clinical evolution

Abstract

Long-term follow-up identified important phenotypic variability in this cohort of 35 BM patients. However, worsening of the functional disability appeared typically after the age of 40 in 47% of our patients, and was frequently associated with COL6A1 exon 14 skipping.